Currently browsing: Inventions/Patents

Another US patent

3/8/2019: US 10,219,559 patent was issued on March 5, 2019 concerning the sports glove that increases the player’s feel in the fingertips.  This results in affecting where the player moves in space.  They can hit a golf ball more accurately.  The can throw a ball more accurately.  They can catch a ball more securely. Go to www.realfeelgloves.com  Listen to hall of fame golfer Bob Toski’s unpaid endorsement. This patent is an addition to prior patents that carefully described the glove design (D827,245) and the glove function; US  10,058,135; US 10,077,967, and US 10,197,357.

Another US Patent Granted

2/14/2019:  I learned today that a US patent will be issued soon concerning my novel formulation for the treatment of skin acne.  This was based upon a two year, four phase study at Loma Linda Medical School.  It features the broad spectrum biofilm destroying nutraceutical, protocatechuic acid.  There are 3 other ingredients in the formulation.  Very thankful.

Food Supplement Cautions

10/25/2018:  There are published cautions about a number of food substances. www.consumerreports.org/vitamins-supplements/15-supplement-ingredients-to-always-avoid/ I have been very cautions as I have explored the health benefits of food supplements.  I have done extensive testing and review of the literature on the food metabolite I am using; protocatechuic acid.  It is safe.  The FDA considers it Generally Recognized As Safe (GRAS) as a food additive for flavoring. My first launch is www.4WhatAilsU.com   This is an antioxidant pill.  The web site has all the information.

Another US Patent issued

10/4/2018:  I learned today that another US Patent issued: 10,077,967 on September 18, 2018.  This is a tape to be attached to equipment, especially a sports handle.  The tape has either a thin longitudinal groove or elevation that makes an impression on the holder’s skin.  This impression allows the holder to have better orientation of the handle.  It is based upon the psychomotor principle know as “tactile edge orientation processing”.  This is fancy wording that means the human can reach into their pocket and discern without looking by feeling the difference between a coin and a key by way of feeling the edge of each. The function in sports is the same principle as the groove golf grip and the glove with holes in the finger tips work.  The player has a better sense of orientation and there for proprioception to be more accurate with performance. PTL

Web Site Launch: www.4WhatAilsU.com

9/15/2018:  I launched www.4WhatAilsU.com this past week on the PGA Champions Tour.  It is offering a Powerful Broad Spectrum anti-oxidant. It is a natural food substance; the metabolite from the dyes that make blueberries blue and cherries red. I had amazing good response and immediate results from first adopters, especially the tour player’s caddies.  

Another US Patent

5/31/2018: On May 29, 2018 I was issued US patent 9,982,963 B2 A firearm having tactile biofeedback reference feature. It is based upon the same human response to sensation in the skin that was present in the grooved grip and the real feel gloves. It allows the person to shoot more accurately.

Expanded US patent for Arthritis joint injection

5/24/2018: Just learned that on June 5, 2018, U.S. Patent No. 9,987,296 will be published. It is a continuation of a prior more general patent for intra articular injection to treat arthritis. This patent expanded the use of the common plant dye, Cyanidin-3-glucoside to include dextrose and addition of insulin or other growth hormones as well as slow release biodegradable vehicle. Allowed Claims 1. A method of inhibiting interleukin-1 (IL-1) induced glycosaminoglycoside (GAG) release in an arthritic joint of a subject, comprising administering into the arthritic joint of the subject by an intra-articular injection, a composition comprising cyanidin-3-glucoside (C3G), glucose and a pharmaceutically acceptable carrier, wherein the concentration of glucose is about 5%, and wherein the C3G is administered at a dose of 0.002 mg to 100 mg per joint that is effective to elicit the inhibition of IL-1 induced GAG release in the arthritic joint of the subject. 2-3. (Cancelled) 4. The method according to claim 1, wherein the composition increases expression of IGF-1 in the arthritic joint. 5. The method according to claim 4, wherein the composition is provided in a biodegradable microsphere. 6. The method according to claim 5, wherein the biodegradable microsphere comprises a slow release bioabsorbable material. 7. The method according to claim 6, wherein the bioadsorbable material is 50/50 D, L lactide/glycolide or 85/15 D, L lactide/glycolide. 8. (Cancelled) 9. The method according to claim 1, wherein the composition has a chondroprotective and/or chondronutritive effect in the joint of a subject. 10. (Cancelled) 11. The method of claim 1, wherein the composition treats damaged cartilage in the arthritic joint. 12-15. (Cancelled) 16. The method of claim 1, wherein the joint is a synovial joint. 17. The method of claim 11, wherein the injection comprises the formation of anthocyanin metabolites in the synovial fluid. 18. The method according to claim 1, wherein the dose of 0.002 mg to 100 mg per joint of C3G is provided at a concentration not exceeding about 100 µM. 19. The method according to claim 1, wherein the composition is administered with IGF-1, insulin, or a mixture thereof. 20. A method for treating damaged cartilage in an arthritic joint in a subject, comprising administering into the arthritic joint of the subject, by an intra-articular injection, a composition that is a solution comprising an anthocyanin, glucose and a pharmaceutically acceptable carrier, wherein the concentration of the glucose is about 0.5% to about 10%; wherein the anthocyanin is cyanidin-3-glucoside (C3G), and wherein the C3G is administered at a dose of 0.002 mg to 100 mg per joint. 21. The method according to claim 20, wherein the composition increases production of insulin-like growth factor-1 (IGF-1) in the joint. 22. The method according to claim 20, wherein the glucose is administered at about 5%. 23. The method according to claim 20, wherein the glucose is administered at about 10%.